Genome‐wide microRNA expression profiling in renal cell carcinoma: significant down‐regulation of miR‐141 and miR‐200c
暂无分享,去创建一个
M. Seto | K. Matsuura | N. Hijiya | T. Uchida | Y. Tsukamoto | M. Moriyama | C Nakada | K Matsuura | Y Tsukamoto | M Tanigawa | T Yoshimoto | T Narimatsu | L T Nguyen | N Hijiya | T Uchida | F Sato | H Mimata | M Seto | M Moriyama | F. Sato | H. Mimata | C. Nakada | T. Yoshimoto | L. Nguyen | T. Narimatsu | Lt Nguyen | M. Tanigawa | Takahiro Narimatsu | Masato Tanigawa
[1] J. Nesland,et al. Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.
[2] Reuven Agami,et al. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .
[3] Y. Kudo,et al. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma , 2007, Virchows Archiv.
[4] F. Lyko,et al. Methylation of Human MicroRNA Genes in Normal and Neoplastic Cells , 2007, Cell cycle.
[5] J. Inazawa,et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. , 2008, Cancer research.
[6] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[7] D. V. van Spronsen,et al. Novel treatments for metastatic renal cell carcinoma. , 2005, Critical reviews in oncology/hematology.
[8] M. Fukayama,et al. Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas. , 2002, The American journal of pathology.
[9] Birgit Luber,et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.
[10] P. Sharp,et al. Embryonic stem cell-specific MicroRNAs. , 2003, Developmental cell.
[11] R Y Ball,et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .
[12] S. Ramaswamy,et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. , 2002, The Journal of clinical investigation.
[13] Wayne Tam,et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[15] G. Landberg,et al. Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray , 2003, British Journal of Cancer.
[16] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[17] Y. Nagashima,et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[18] I. Lorimer,et al. Regulation of p27Kip1 by miRNA 221/222 in Glioblastoma , 2007, Cell cycle.
[19] F. Erdoğan,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 2004, International journal of clinical practice.
[20] D. Valle,et al. DNA methylation regulates microRNA expression , 2007, Cancer biology & therapy.
[21] Leonard D. Goldstein,et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels , 2007, The Journal of pathology.
[22] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Burge,et al. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.
[24] Matteo Brunelli,et al. Original and reviewed nuclear grading according to the Fuhrman system , 2005, Cancer.
[25] B. Reinhart,et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.
[26] George A Calin,et al. Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.
[27] J. Mestan,et al. Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Hutvagner,et al. Principles and effects of microRNA-mediated post-transcriptional gene regulation , 2006, Oncogene.
[29] O. Kallioniemi,et al. Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses , 2006, Oncogene.
[30] J. Foidart,et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.
[31] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[32] C. Pan,et al. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases , 2004, Histopathology.
[33] Sun-Mi Park,et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.
[34] Simion I. Chiosea,et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. , 2007, Cancer research.
[35] Y Zeng,et al. Principles of micro-RNA production and maturation , 2006, Oncogene.
[36] Reuven Agami,et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. , 2007, The EMBO journal.
[37] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[38] M. Esteller. Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.
[39] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] J Wade Harper,et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] Jianhong Luo,et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death , 2007, Molecular Cancer Therapeutics.
[42] H. Tagawa,et al. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. , 2008, The Journal of pathology.
[43] Ludger Hengst,et al. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy , 2008, Nature Reviews Cancer.
[44] Rajiv Dhir,et al. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. , 2006, The American journal of pathology.
[45] Stefano Volinia,et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[46] I. Lorimer. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. , 2009, Cell cycle.
[47] P. Rehak,et al. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique , 2004, Virchows Archiv.